Bruce joined Pharmaterials in June 2008 from another contract research organisation, where he managed a group of some 15 scientists providing a wide range of formulation development services, from conventional solid dosage forms, through to complex modified release and rapid release systems.  Bruce will be managing the same services provision within Pharmaterials

Bruce also has extensive skills in formulation for poorly soluble drug substances, from his previous position and from early work at other companies (including RPR).  He has also worked extensively in the field of pharmaceutical physical form and salt selection and will lead the Pharmaterials screening team.